Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Yau T., Merle P., Rimassa L., Ryoo B., Cicin I., Harris W. P., ...More

European-Society-for-Medical-Oncology Asia Congress, Singapore, Singapore, 23 - 25 November 2018, vol.29, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Singapore
  • Country: Singapore
  • Trakya University Affiliated: Yes